Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7676240 | 0.97 | CD44 (0.94) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL943759 | 0.86 | CD44 (0.75) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL203360 | 0.86 | CD44 (0.75) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL29739478 | 0.86 | CD44 (0.75) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL8341703 | 0.86 | CD44 (0.75) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL9634914 | 0.86 | CD44 (0.75) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL2026149 | 0.80 | GAA (0.67) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL29683620 | 0.80 | GAA (0.67) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL405877 | 0.79 | CD44 (0.65) | CD44GAACYP3A4TSHRMAPK1 | |
| SCHEMBL4544583 | 0.79 | CD44 (0.65) | CD44GAACYP3A4TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130102049-A1 | REMOVABLE SACCHARIDE-BENZIMIDAZOLE (BIM) TAGS AND CONJUGATES THEREOF VIA 1H-POSITION OF THE BENZIMIDAZOLES | ACADEMIA SINICA (TW) | 2013-04-25 | — | — | US | claimed |
| CN-119487024-A | Herbicidal compounds | 先正达农作物保护股份公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2023247301-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023247301-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2023-12-28 | — | — | WO | disclosed |
| EP-1812406-B1 | NOVEL BENZIMIDAZOLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) | JANSSEN PHARMACEUTICA NV (BE) | 2018-09-12 | — | — | EP | disclosed |
| US-9527850-B2 | Benzyl piperidine compounds as lysophosphatidic acid (LPA) receptor antagonist | MERCK PATENT GMBH (DE) | 2016-12-27 | — | — | US | disclosed |
| US-9527850-B2 | Benzyl piperidine compounds as lysophosphatidic acid (LPA) receptor antagonist | MERCK PATENT GMBH (DE) | 2016-12-27 | — | — | US | disclosed |
| EP-2844648-B1 | BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST | MERCK PATENT GMBH (DE) | 2016-11-09 | — | — | EP | disclosed |
| EP-2844648-B1 | BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST | MERCK PATENT GMBH (DE) | 2016-11-09 | — | — | EP | disclosed |
| US-20160194308-A1 | NOVEL PIPERIDINYL BENZOIMIDAZOLE DERIVATIVES AS MPGES-1 INHIBITORS | NOVASAID AB (SE) | 2016-07-07 | — | — | US | disclosed |
| CN-1158610-A | Quinoxaline derivatives useful in therapy | PFIZER LTD (IE) | 1997-09-03 | — | — | CN | disclosed |
| WO-1996009295-A1 | QUINOXALINE DERIVATIVES USEFUL IN THERAPY | PFIZER LIMITED (GB) | 1996-03-28 | — | — | WO | disclosed |
| US-5493011-A | PIGMENTING HIGH MOLECULAR WEIGHT NATURAL OR SYNTHETIC ORGANIC MATERIALS | HOECHST AG (DE) | 1996-02-20 | — | — | US | disclosed |
| EP-0518909-B1 | WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE | HOECHST AG (DE) | 1994-05-25 | — | — | EP | disclosed |
| EP-0518909-A1 | WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE. | HOECHST AG (DE) | 1992-12-23 | — | — | EP | disclosed |
| WO-1991013941-A1 | WATER-INSOLUBLE AZO DYES, THEIR MANUFACTURE AND USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-09-19 | — | — | WO | disclosed |
| US-4167569-A | ANTICOAGULANTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-09-11 | — | — | US | disclosed |
| US-4138568-A | NITRO-O-PHENYLENEDIAMINE, UREA, HALOBENZENE SOLVENT | CIBA-GEIGY CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
| US-4008225-A | Process for the manufacture of bis-azomethine metal complex colorants | CIBA-GEIGY CORPORATION (US) | 1977-02-15 | — | — | US | disclosed |
| US-3963708-A | Bis-azomethine metal complex colorants from hydroxycoumarin derivatives or hydroxychromone derivatives | CIBA-GEIGY CORPORATION (US) | 1976-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194308-A1 | NOVEL PIPERIDINYL BENZOIMIDAZOLE DERIVATIVES AS MPGES-1 INHIBITORS | FAP, APC, PTGES | CD44 4876/4885GAA 2065/4885CYP3A4 2117/4885 |
| US-20130102049-A1 | REMOVABLE SACCHARIDE-BENZIMIDAZOLE (BIM) TAGS AND CONJUGATES THEREOF VIA 1H-POSITION OF THE BENZIMIDAZOLES | SORD, BTD, DERA | CD44 135/4885GAA 513/4885CYP3A4 1179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.